(R)-Viloxazine Hydrochloride

CAS No. 56287-63-9

(R)-Viloxazine Hydrochloride( —— )

Catalog No. M33812 CAS No. 56287-63-9

(R)-Viloxazine Hydrochloride is the R-isomer of Viloxazine, a selective norepinephrine reuptake inhibitor (NRI) used as an antidepressant.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 98 In Stock
5MG 107 In Stock
10MG 157 In Stock
25MG 236 In Stock
50MG 324 In Stock
100MG 442 In Stock
200MG 594 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    (R)-Viloxazine Hydrochloride
  • Note
    Research use only, not for human use.
  • Brief Description
    (R)-Viloxazine Hydrochloride is the R-isomer of Viloxazine, a selective norepinephrine reuptake inhibitor (NRI) used as an antidepressant.
  • Description
    (R)-Viloxazine hydrochloride is a less active R-isomer of Viloxazine hydrochloride. Viloxazine hydrochloride is an effective antidepressant agent.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Endocrinology/Hormones
  • Target
    Reductase
  • Recptor
    Reductase
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    56287-63-9
  • Formula Weight
    273.76
  • Molecular Formula
    C13H20ClNO3
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    Cl.CCOc1ccccc1OC[C@H]1CNCCO1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. R Howe, et al. Optical isomers of 2-(2-ethoxyphenoxymethyl)tetrahydro-1,4-oxazine (viloxazine) and related compounds. J Med Chem. 1976 Aug;19(8):1074.?
molnova catalog
related products
  • AT-007

    AT-007 is an orally active CNS penetrant Aldose Reductase inhibitor for the treatment of Galactosemia (IC50: 100 pM).

  • Sorbinil

    Sorbinil is an Aldose reductase inhibitor. Sorbinil plays a therapeutic role in treating diabetes and diabetic complications decreases AR activity and inhibit the polyol pathway.

  • Ponalrestat

    ponalrestat, an aldose reductase inhibitor, activates lipoprotein lipase (LPL) activity in the adipose tissue and alleviates the cachectic symptoms induced by B16 melanoma in mice